MedTrace Logo

Pectoral Nerve Blockade in Mastectomy

NCT01943240 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2016-10-27

No results posted yet for this study

Summary

Our routine practice for patients undergoing mastectomy is to include paravertebral peripheral nerve blockade for postoperative analgesia. This study investigates whether the addition of another nerve block targeting the pectoral nerves will improve that analgesia.

Conditions

Interventions

DRUG

Paravertebral nerve block: 4 mL ropivacaine 0.5% at each of six levels

DRUG

10 cc of 0.375% ropivacaine pectoral nerve block

Sponsors & Collaborators

  • Timothy R Petersen

    lead OTHER

Principal Investigators

  • Nicholas Lam, MD · University of New Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943240 on ClinicalTrials.gov